BIM
EBS icon

BlackRock Investment Management’s Emergent Biosolutions EBS Stock Holding History

BlackRock Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.51M Buy
167,949
+31,227
+23% +$936K 0.01% 1525
2016
Q3 		$4.31M Buy
136,722
+1,462
+1% +$42.5K 0.01% 1585
2016
Q2 		$3.8M Buy
135,260
+13,675
+11% +$536K ﹤0.01% 1628
2016
Q1 		$4.42M Buy
121,585
+3,138
+3% +$111K 0.01% 1455
2015
Q4 		$4.74M Buy
118,447
+1,114
+0.9% +$38.8K 0.01% 1431
2015
Q3 		$3.34M Sell
117,333
-1,848
-2% -$60.9K ﹤0.01% 1664
2015
Q2 		$3.93M Buy
119,181
+12,071
+11% +$374K ﹤0.01% 1690
2015
Q1 		$3.08M Buy
107,110
+1,261
+1% +$36.2K ﹤0.01% 1727
2014
Q4 		$2.88M Sell
105,849
-1,418
-1% -$33.8K ﹤0.01% 1752
2014
Q3 		$2.29M Buy
107,267
+1,311
+1% +$30K ﹤0.01% 1903
2014
Q2 		$2.38M Sell
105,956
-845
-0.8% -$19.7K ﹤0.01% 1949
2014
Q1 		$2.7M Buy
106,801
+1,299
+1% +$32.8K ﹤0.01% 1828
2013
Q4 		$2.42M Sell
105,502
-1,680
-2% -$35K ﹤0.01% 1888
2013
Q3 		$2.04M Buy
107,182
+4,308
+4% +$76.9K ﹤0.01% 1948
2013
Q2 		$1.48M Buy
+102,874
New +$1.49M ﹤0.01% 2080

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's EBS Position: Q4 2016 in Review

BlackRock Investment Management increased its Emergent Biosolutions (EBS) stake by 23% in Q4 2016, buying an estimated $936K and bringing the position to 167,949 shares worth $5.51M. The position accounts for 0.01% of the portfolio, ranked #1525.

BlackRock Investment Management first reported a position in EBS in Q2 2013 and has held it in 15 quarters since. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.

  • BlackRock Investment Management held 167,949 shares of Emergent Biosolutions worth $5.51M as of Q4 2016.
  • BlackRock Investment Management bought 31,227 Emergent Biosolutions shares in Q4 2016, an estimated $936K.
  • Emergent Biosolutions made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1525 holding.
  • BlackRock Investment Management first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 15 quarters since.
  • 208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.